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Abstract
Fomitopsis betulina (Bull.) B.K. Cui, M.L. Han & Y.C. Dai has been used for medicinal purposes for over 5000 years. 
Numerous studies have confirmed the biological activity of compounds found in this species. The purpose of this study was 
a comparative analysis of selected groups of metabolites in the extracts from fruiting bodies and mycelial cultures. Phenolic 
acids (syringic, gallic, p-hydroxybenzoic, 3,4-dihydrophenylacetic), indole compounds (l-tryptophan, 5-hydroxy-l-tryp-
tophan, 5-methyltryptamine), sterols (ergosterol, ergosterol peroxide, hexestrol, cholecalciferol), and triterpenes (betulinic 
acid, betulin) were determined quantitatively by high performance liquid chromatography with UV–Vis/DAD detection, 
while fatty acids were assessed with the gas chromatography method. Cytotoxic activity against selected human cancer cell 
lines was determined using the lactate dehydrogenase test. Anti-inflammatory activity was evaluated on lipopolysaccharide 
activated A549 cells. Those extracts with anti-inflammatory activity were evaluated for their inhibition of pro-inflammatory 
enzymes. The mycelium extract exhibited significant cytotoxic activity against prostate cancer cells, while the fruiting body 
extract indicated a moderate effect on the viability of melanoma and prostate cancer. Incubation of lung epithelial cells with 
biomass extract significantly decreased cyclooxygenase-2 levels compared to LPS activated A549 cells. This paper is the first 
report of a comparative quantitative analysis of the metabolites in mycelial cultures and fruiting bodies. In addition, a novel 
element of this study is its comparison of the cytotoxic and anti-inflammatory activity of the obtained extracts. The results 
of comparing the composition and activity of mycelium and fruiting bodies shows that the cultures could be proposed as a 
potential biotechnological source for selected biologically active compounds.
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Introduction
Fomitopsis betulina (Bull.) BK Cui, ML Han and YC Dai 
[formerly Piptoporus betulinus Bull. P. Karst.—(birch poly-
pore)] from the family of Fomitopsidaceae (Basidiomycota) 
is a common species of arboreal mushroom [1]. A charac-
teristic feature of this species is the colonization of both 
living and dead individuals of Betula sp. genus. This is an 
inedible species; however, young fruiting bodies are suit-
able for consumption [2]. The oldest evidence of the use of 
F. betulina fruiting bodies by humans is the discovery of 
fragments with the remains of the ice man—Ötzi, who lived 
5300 years ago (3300 BC). This fact allows the conclusion 
that the fruiting bodies of this species were used for healing 
purposes [3]. The fruiting bodies of F. betulina have also 
been widely used in folk medicine due to their antimicro-
bial properties that accelerate wound healing. The fruiting 
bodies have also been employed as a laxative and adjuvant 
in stomach disorders [3]. Most of the potential therapeutic 
applications described above have been confirmed in scien-
tific studies. Aqueous extracts and pentacyclic triterpenes 
isolated from fruiting bodies exhibit immunomodulatory and 
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anticancer effects [4]. Ethanol-acetate extract and single trit-
erpene derivatives of lanostane exhibit anti-inflammatory 
activity [5]. Another documented effect is its antioxidant 
activity and the ability to inhibit hyaluronidase, an enzyme 
depolymerizing hyaluronic acid and causing the inhibition 
of acetylcholinesterase, which is used in the symptomatic 
treatment of Alzheimer’s disease [6].
An alternative method to obtain secondary metabolites 
with therapeutic properties from fruiting bodies is to use 
the biosynthetic capability of mycelial cultures. The main 
advantage of mycelial cultures is their independence from 
environmental conditions and their ability to continuously 
produce high-quality material; however, there may be differ-
ences in the chemical composition of mycelium and fruiting 
bodies [7].
The chemical composition of biomass extracts from 
mycelial cultures of F. betulina has so far only been studied 
to a limited extent. However, the anticancer properties of the 
extracts have been proven [8].
A challenge facing modern science are the so-called civi-
lization diseases, which include cancer diseases. Inflamma-
tion, a factor often preceding the formation of a tumor, plays 
an important role in the process of oncogenesis and cancer 
progression. Studies have proved the existence of a feedback 
mechanism that allows chronic inflammation to be connected 
with metastasis. Inflammatory responses play decisive roles 
at different stages of tumor development, including initia-
tion, promotion, malignant conversion, invasion, and metas-
tasis [9]. This observation led us to study the cytotoxic and 
anti-inflammatory potential of extracts from fruiting bodies 
and from mycelial cultures of F. betulina.
The present study is the first to present a comparative 
analysis of groups of bioactive metabolites in extracts from 
fruiting bodies and from mycelial cultures. The multidirec-
tional biological activity of extracts from fruiting bodies and 
biomass of F. betulina has so far been explained mainly by 
the activity of polysaccharides and triterpenes. A compre-
hensive understanding of the qualitative and quantitative 
profiles of the groups of metabolites (sterols, indole deriva-
tives, phenolic acids and fatty acids) was established using 
chromatographic methods. In addition, for the first time, the 
cytotoxic and anti-inflammatory activities of the obtained 
extracts were compared using in vitro methods.
Materials and methods
The fruiting bodies were collected in 2014 in the mixed for-
ests of northern Poland. Representative samples were depos-
ited at the Department of Pharmaceutical Botany, Jagiellon-
ian University Medical College, Kraków.
Mycelial cultures were isolated from the internal 
part of the fruiting bodies. Pieces of sporocarps were 
surface-sterilized with 70% ethanol for 2 min. Then, these 
were rinsed three times with sterile water and placed on 
Oddoux medium [10]. Initial cultures were grown for three 
weeks at 22 ± 2 °C under a 16/8 h light/dark period. The 
experimental cultures were maintained as submerged cul-
tures on Oddoux medium. Medium was inoculated with 
3-week-old initial cultures. The cultures (three series) were 
maintained for 3 weeks, under the same light and tempera-
ture conditions as the initial cultures, on an Alltel rotary 
shaker operating at 140 rpm with a vibration amplitude of 
35 mm. After separation from the medium, the obtained 
mycelium was frozen and lyophilized (lyophilizer Free-
zone 4.5, Labconco, USA) at − 40 °C. After lyophilization, 
materials were ground in a mortar and used for chemical 
analyses.
Extraction and HPLC analysis of phenolic acids
Two grams of material was extracted by boiling methanol (at 
67.4 °C) for 2 h under a reflux condensor. Combined extracts 
(200 mL) were concentrated to dryness using a rotary vac-
uum evaporator (Büchi) at 40 °C. Residues were dissolved 
in 10 mL of methanol. The filtered sample (Millipore PTFE 
membrane, 0.45 µm) was injected (20 µL) in an HPLC 
column. The HPLC method was followed according to a 
procedure described previously [11]. HPLC analyses were 
conducted using a Hitachi HPLC VWR apparatus: pump 
L-2130, RP-18e column (250 mm × 4 mm, 5 µm) thermo-
stated at 25 °C, and diode array detector (DAD) L-2455 at 
UV range 200–400 nm.
The gradient program was as follows: 0–20 min, 0% B; 
20–35 min, 0–20% B; 35–45 min, 20–30% B; 45–55 min, 
30–40% B; 55–60 min, 40–50% B, 60–65 min, 50–75% B; 
and 65–70 min, 75–100% B, with a hold time of 15 min, 
at 25 °C. The flow rate was 1.0 mL/min. Comparison of 
UV spectra at λ = 254 and retention times with standard 
compounds enabled identification of phenolic acids pre-
sent in the analyzed samples. Phenolic acid standards were 
purchased from Fluka (Chemie AG) and Sigma (St. Louis, 
USA).
Extraction and GC analysis of fatty acids
One gram of material was extracted with a chloro-
form–methanol solution, 2:1 (v/v). Fatty acid methyl esters 
(FAME) were synthesized using 20%  BF3 in methanol at 
100 °C. FAME analyses were performed using gas chroma-
tography (GC) on an Agilent 6890N with a J and W DB-23 
capillary column (60 m, ID 0.25 mm, 0.25 µm) and FID 
detector. Chromatography parameters—FID 260 °C, injec-
tor 250 °C, split ratio 50:1, oven 140 °C for 5 min—ranged 
from 140 to 190 °C at 4 °C/min, 190 °C for 15 min, and from 
190 to 240 °C at 2.75 °C /min, 240 °C for 4 min, carrier 
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gas—helium. For the identification of fatty acids, retention 
times of FAME standards from Supelco (47801) were used. 
Peak areas were measured with an integrator (ChemStation). 
The results for fatty acid (FA) composition, total saturated 
fatty acids (SFA), monounsaturated fatty acids (MUFA) and 
polyunsaturated fatty acids (PUFA) of the samples were 
expressed as relative % of total fatty acids.
Extraction and HPLC analysis of sterols
Five grams of material was extracted with a mixture of meth-
anol/dichloromethane, 75:25 (v/v). The mixture was soni-
cated at 40 kHz for 10 min. After 2 h, the extract was centri-
fuged at 12,000 rpm for 5 min and decanted. The extraction 
procedure was repeated twice and obtained extracts were 
mixed and evaporated under reduced pressure.
The filtered sample (Millipore PTFE membrane 0.45 µm) 
was injected (20 µL) into the HPLC column. Analyses were 
conducted using a Hitachi HPLC VWR liquid chromato-
graph (Merck, Germany), as described above.
The HPLC method was followed according to the proce-
dure developed by Yuan [12] with our own modifications 
concerning the gradient procedure. The mobile phase con-
sisted of solvent A: methanol/water 80:20 (v/v), and sol-
vent B: methanol/dichloromethane 75:25 (v/v The gradient 
program was as follows: 0–10 min, 80:20% B; 10–35 min, 
40–60% B; 35–50 min, 0–100% B; 50–55 min, 80–20% B; 
with a hold time of 15 min, at 25 °C). The flow rate was 
1.0 mL/min. The chromatographic peaks were recorded at 
a wavelength of 280 nm. Sterol standards were purchased 
from Fluka (Chemie AG).
Extraction and HPLC analysis of triterpenoids
One gram of material sample was mixed with 10 mL metha-
nol 95% containing 1% HCl conc. and then homogenized 
under sonication for 15 min. After 30 min, the extract was 
filtered through a paper and Millipore PTFE membrane 
(0.45 µm).
The HPLC method was followed according to the proce-
dure developed by Holonec [13]. The filtered sample was 
injected (20 µL) into the HPLC column. HPLC analyses 
were conducted using a Hitachi HPLC VWR liquid chroma-
tograph (Merck, Germany), as described above. An isocratic 
separation was applied, for which the mobile phase consisted 
of acetonitrile: water, 9:1, flow 1 mL/min. at temperature 
25 °C and wavelength at 210 nm. Triterpenoid standards 
were purchased from Sigma (St. Louis, USA).
Determination of indole derivatives
Five grams of material was extracted with 100 mL of 
methanol for 2  h in a magnetic stirrer. The obtained 
extracts were combined and concentrated to dryness. The 
HPLC method was carried out according to the proce-
dure described by Muszyńska [14]. Briefly, the conditions 
were as follows: Hitachi HPLC; pump L-7100; column 
Purospher RP-18 (250 mm × 4 mm, 5 µm). Isocratic sep-
aration was used, and the mobile phase was: methanol: 
water: ammonium acetate 15:14:1 (v/v/v); flow 1 mL/min. 
Chromatographic peaks were recorded at a wavelength of 
280 nm. Indole standards were purchased from Sigma (St. 
Louis, USA).
Cytotoxicity determination
Five grams of material was extracted three times with 
100 mL of methanol for 24 h in a magnetic stirrer. The 
obtained extracts were combined and concentrated to 
dryness.
A cytotoxicity determination was performed on human 
cancer cells and their corresponding normal cells. Pros-
tate cancer and melanoma lines, grouped into panels, were 
used for this purpose. The prostate panel comprised DU145 
cancer cells as well as normal epithelial cells of the pros-
tate—PNT-2. The melanoma panel comprised the WM795 
and A375 cell lines differing in metastatic potential as well 
as the reference normal cells of skin fibroblasts—BJ. All 
the cell lines were commercial (ATCC) and remained in a 
continuous culture at the Department of Pharmacognosy, 
Jagiellonian University Medical College (Poland). Cells 
were grown on media (DMEM F12, DMEM high glucose) 
with 10% bovine serum and a mixture of antibiotics in an 
incubator with 5%  CO2 at 37 °C and constant humidity. The 
cytotoxic activity of the tested extracts was measured with 
the LDH viability test, according to a procedure described 
previously [15]. Each experiment was repeated three times. 
The cytotoxicity of the samples was measured as follows: % 
cytotoxicity = [(Asample − Aspont): (Amax − Aspont)] × 100 
where Asample is the absorbance value for the cells treated 
with the tested substances, Aspont is the value for the spon-
taneous LDH release and Amax the value in lysed cells in 
the presence of Triton × 100.
Anti‑inflammatory activities
Cell cultures
A549 Human Lung Carcinoma Epithelial Cells (CCL-185, 
ATTC, Manassas, VA, USA) were cultured as described 
previously [16]. Cells were activated by LPS 1 µg/mL for 
24 h. After this time, lung epithelial cells were incubated 
with 10 µL or 25 µL of methanolic extract from biomass and 
fruiting bodies for 24 h.
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Western blot
Cell lysates were prepared and subjected to 10% SDS–poly-
acrylamide gel electrophoresis, as described earlier [16]. The 
experiments used primary antibodies anti-cyclooxygenase 2 
(COX-2) and anti-β-actin (GeneTex Inc., Irvine, CA, USA), 
diluted 1:1000 and the secondary antibody anti-rabbit IgG 
(HRP) diluted 1:2000 (ThermoFisher Scientific, Waltham, 
MA, USA). The integrated optical density of the bands was 
quantified using a Chemi Doc Camera with Image Lab soft-
ware (Bio-Rad, Hercules, CA, USA).
Statistical analysis
Values are presented as means ± SD. All experiments 
were performed four times. Using one way ANOVA with 
Tukey–Kramer post hoc method of multiple comparisons, 
statistical analysis of the data was performed. The value 
p < 0.05 was accepted as the level of statistical significance.
Results and discussion
The use of mycelial cultures of macrofungi for experimen-
tal and medical purposes is a promising and reproducible 
method that enables efficient production of fungal biomass 
and its metabolites [17]. Differences in the content of bioac-
tive compounds in fruiting bodies derived from natural sites 
may result not only from genetic differences between popu-
lations, but also from different habitats and environmental 
conditions during growth and development. Differences 
in the amounts of bioactive compounds such as polysac-
charides, terpenoids, steroids and phenolic compounds are 
much lower under the controlled, reproducible conditions 
of mycelial cultures.
After a 3-week growth cycle, the biomass increments 
were on average 9.5 g dry mass per liter. Obtained biomass 
increments and growth dynamics did not differ from the 
results obtained previously by other researchers [18]. The 
applied methods for extraction and HPLC analysis provided 
the opportunity to obtain optimal conditions for the qualita-
tive and quantitative determination of selected compounds 
in the examined material. Previous analysis of the chemical 
composition of fruiting bodies of F. betulina had demon-
strated that they mainly contain carbohydrates, terpene com-
pounds, sterols, fatty acids and aromatic compounds [19]. 
Chemical biomass composition has so far been studied only 
to a limited extent.
In contrast, biological activity studies have focused 
on extracts. Cyranka et al. demonstrated that the type of 
mycelial extract has an effect on the growth and viability 
of colon adenocarcinoma cells [8]. Moreover Pleszczyńska 
et al. showed the anti-proliferative and anti-immigration 
properties of water and ethanol extracts from fruiting bod-
ies against human cancer cells [20].
The total content of phenolic acids in the biomass 
obtained from mycelial cultures was 22.56 mg/100 dry mass 
(DM.). The total content of phenolic acids in fruiting bodies 
was 37.08 mg/100 DM. Syringic, gallic, 5-hydroxybenzoic 
and 3,4-dihydrophenylacetic acids were determined in myce-
lium and fruiting bodies (Table 1).
Phenolic acids identified both in fruiting bodies and 
mycelial culture show a broad spectrum of biological activ-
ity of antioxidant, antibacterial, antiviral, antifungal and 
anti-inflammatory nature. Particularly noteworthy is the 
antioxidant activity of phenolic acids. A deficiency of these 
acids induces the human body into a state of chronic oxida-
tive stress, the consequence of which may be chronic inflam-
mation that leads to the development of many diseases.
Syringic acid determined in mycelial cultures also exhib-
its a choleretic activity, while in turn gallic acid possesses 
antiseptic, astringent and antiperspirant activity.
The most common phenolic acids in fruiting bodies of 
higher mushrooms include protocatechuic acid, gallic acid, 
p-hydroxybenzoic acid, gentisic acid, caffeic acid, and syrin-
gic and vanillic acids. Veratryl, p-coumaric, caffeic, ferulic 
or cinnamic acids are less common [21]. Phenolic acids are 
compounds important for the survival of fungal organisms, 
as evidenced by the various biogenetic pathways leading to 
their formation. Similar to the situation in plants, phenolic 
acids play a defensive role against parasites and microorgan-
isms in mushrooms. Their insecticidal, anti-bacterial and 
anti-microbial properties are known [22].
In both mycelium and fruiting bodies eleven fatty acids 
were identified. The results of the analysis are presented in 
Table 2.
The amounts of individual compounds were within a wide 
range—from about 35.8% (palmitic acid) to 0.4% (palmito-
oleic acid)—in the extracts obtained from biomass. In turn, 
in extracts from fruiting bodies, the amounts range from 
41.6% (stearic acid) to 0.4% (cis-10-pentadecanoic acid). 
The amount of palmitic acid is 2.5-fold higher, and that of 
myristoleic acid is ninefold higher in extracts obtained from 
biomass than in extracts from fruiting bodies. However, most 
interesting is the fact that the concentration of linoleic acid 
is up to 23-fold higher in extracts obtained from mycelial 
biomass cultures than in extracts of fruiting bodies.
Linoleic acid (LA) belongs to the group of essential fatty 
acids (EFAs). It is a precursor of arachidonic acid, the com-
ponent of bile and octen-3-ol which gives mushrooms their 
characteristic aroma. In addition, LA reduces the total fat in 
the blood and, as a result, reduces the risk of cardiovascular 
diseases [15, 16]. A high intake of dietary n-6 polyunsatu-
rated fatty acid contributes to excess chronic inflammation. 
For linoleic acid (LA), as a precursor of long-chain fatty 
acids from the n-6 family, there is no evidence that a high 
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intake of LA with the diet influences the level of inflamma-
tory markers in blood [23].
Fatty acids contained in mushrooms may support anti-
inflammatory processes in the human organism, due to the 
high content of unsaturated fatty acids [24, 25].
Polyunsaturated fatty acids (PUFAs) are precursors of 
eicosanoids, signaling molecules necessary for proper regu-
lation of cellular processes in muscles, blood vessels, nerve 
cells and in the immune system. Eicosanoids provide a bal-
ance between inflammatory and anti-inflammatory processes 
Table 1  Quantitative 
comparison of studied groups 
of compounds in fruiting bodies 
and biomass of Fomitopsis 
betulina 
Data are presented as the mean ± SD (standard deviation); n = 3 repetitions. Tukey test was used to reveal 
the differences between paired groups of elements in rows, the same letters (a, b, c) are marked for which 
the content differences are statistically significant (for p values < 0.05); (GraphPad InStat)
Name of compounds Amounts of compounds [mg/100 g DM]
Fruit bodies Biomass from 
mycelial cultures
Non hallucinogenic indole derivatives
 l-Tryptophan 2.03 ± 0.83a 1.34 ± 0.28a
 5-Hydroxy-l-tryptophan 3.05 ± 1.02a,b 2.74 ± 0.62
 5-Methyltryptamine 5.25 ± 1.6 a,b 3.99 ± 0.95a
Phenolic acids
 Syringic acid 0.99 ± 0.86a 1.08 ± 0.74a
 Gallic acid 7.55 ± 1.30a,b 4.02 ± 1.01a,b
 5-Hydroxybenzoic acid 10.88 ± 1.20a,b,c 9.11 ± 1.29a,b
 3,4-Dihydrophenylacetic acid 6.55 ± 0.82a,c 8.04 ± 0.98a,b
Triterpenes
 Betulin 0.00209 ± 0.00102 0.0006 ± 0.00022
 Betulinic acid 0.00085 ± 0.00068 0.00031 ± 0.00037
Sterols
 Ergosterol 103.99 ± 2.63a 41.29 ± 2.87a
 Hexestrol 3.55 ± 0.71a,b 4.01 ± 1.75a,b
 Ergosterol peroxide 11.88 ± 0.87a,b,c 17.11 ± 1.50a,b,c
 Cholecalciferol 6.55 ± 0.04a,b,c 0.31 ± 0.30a,c
Table 2  Quantitative 
comparison of fatty acids in 
fruiting bodies and biomass of 
Fomitopsis betulina 
Data are presented as the mean ± SD (standard deviation); n = 3 repetitions. Tukey test was used to reveal 
the differences between paired groups of elements in rows, the same letters (a,b,c,d,e) are marked for which 
the content differences are statistically significant (for p values < 0.05); (GraphPad InStat)
Common names of fatty acids Lipid numbers Amounts of fatty acids [%]
Extract from fruit bodies Extract from in vitro cultures
SFA
 Capric acid C10:0 5.42 ± 1.76a 1.06 ± 0.01a
 Lauric acid C12:0 14.13 ± 1.75a,b 0.59 ± 0.09a,b
 Myristic acid C14:0 1.29 ± 0.1b,c 0.67 ± 0.29 a,c
 Pentadecanoic acid C15:0 29.53 ± 2.73a,b,c,d 0.91 ± 0.47a,d
 Palmitic acid C16:0 13.82 ± 2.50a,c,d,e 35.8 ± 1.53b,c,d,e
 Stearic acid C18:0 41.60 ± 3.03a,b,c,d,e 17.01 ± 0.98b,c,d,e
MUFA
 Myristoleic acid C14:1n5 1.71 ± 0.87a 15.30 ± 2.96a
 Palmitooleic acid C16:1c 2.82 ± 1.84b 0.42 ± 0.64a
 Oleic acid C18:1w9 40.78 ± 2.46a,b,c 2.86 ± 0.08a
 Cis-10-pentadecanoic acid C15:1 0.43 ± 0.57c 0.55 ± 0.53a
PUFA
 Linoleic acid C18:2w6 1.1 ± 0.95 25.3 ± 0.82
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[26]. PUFAs include the n-3, n-6 and n-9 series acids. Main-
taining the correct proportions of fatty acids from the n-3 
to n-6 series in the diet is crucial in preventing the develop-
ment of cardiovascular diseases or cancers. α-Linolenic acid 
(ALA) is an essential ingredient in normal nutrition; it is a 
precursor to the long-chain PUFAs of the n-3 series. It also 
exhibits anti-inflammatory activity [27].
Sterols determined in mycelial cultures of F. betulina 
included ergosterol (41.29 mg/100 g D.), cholecalciferol 
(0.30 g DM), ergosterol peroxide and hexestrol. The results 
of the quantitative analysis are presented in Table 1.
Sterols are common ingredients of fruiting bodies of most 
Basidiomycota representatives. The most common is ergos-
terol. Ergosterol and its peroxide are essential for the proper 
development of the hyphae of higher fungi. Ergosterol (pro-
vitamin  D2) is one of the main components of fungal cell 
membranes. It has anti-cancer and immunostimulating prop-
erties and is also a precursor of cortisol, an adrenal hormone 
with anti-inflammatory activity.
Numerous studies have shown that ergosterol and its per-
oxidation products (ergosterol peroxide) show a therapeutic 
effect by reducing the pain related to inflammation, reducing 
the incidence of cardiovascular disease and inhibiting the 
action of cyclooxygenase enzymes (COX) [28]. Ergosterol 
present in the fruiting bodies of edible mushrooms (e.g., 
Imleria badia and A. bisporus) has an anti-inflammatory 
and anticancer activity [19]. Anti-inflammatory properties in 
the mouse model have also been demonstrated for Lentinula 
edodes extract, which is rich in ergosterol. Supplementation 
with L. edodes extract enriched with vitamin D using UV-B 
radiation in C57B1/6 mice with mitogen-induced (conca-
navalin A) liver inflammation causes a significant reduction 
in liver damage. The histopathological image of tissues is 
improved and also the plasma level of transaminases and 
INF-γ decreased. In addition, the anti-inflammatory effect 
of vitamin D and fungal extract is synergistic [29].
In the study material, three indole derivatives were 
determined: 5-hydroxy-l-tryptophan, 5-methyltryptamine 
and l-tryptophan in the both type of extracts.. Quantitative 
results are presented in Table 1. The largest amount was 
found in the case of 5-methyltryptamine (3.99 mg/100 g DM 
in mycelial cultures), while the smallest was for l-tryptophan 
(1.34 mg/100 g DM on in mycelial cultures). The total con-
tent of indole compounds in the biomass was 8.07 mg/100 g 
DM and in the fruiting bodies 10.33 mg/100 g DM.
l-tryptophan and 5-hydroxy-l-tryptophan identified in 
mycelial cultures are observed in in vitro cultures of numer-
ous edible species of Sarcodon imbricatus, I. badia and Can-
tharellus cibarius [30–32]. The concentrations of these two 
indole derivatives are higher in the mycelial cultures of the 
above-mentioned species than in the cultures of F. betulina, 
with the exception of I. badia cultures. The concentration 
of 5-hydroxytryptophan in the mycelium of this species was 
lower than 1 mg/100 g DM, whereas in F. betulina its con-
tent was 2.738 mg/100 g DM 5-Methyltryptamine, present 
at a concentration of 3.99 mg/100 g DM in the mycelium 
of F. betulina, is virtually not noted in the fruiting bodies 
of L. edodes and Leccinum scabrum [33]. l-Tryptophan and 
5-hydroxytryptophan have a sleep-depriving effect and sup-
port the treatment of depression. They are also precursors of 
serotonin and melatonin—endogenous substances responsi-
ble for regulating the circadian cycle of our body. Serotonin 
also has proven antioxidant and anti-cancer properties.
Chromatographic analysis showed the presence of two 
peaks characteristic of betulin and betulinic acid. HPLC 
chromatogram of triterpenes separation in mycelial cul-
tures shows Fig. 1. In fruiting bodies, the content of betulin 
and betulinic acid was 0.0006 and 0.00031 mg/100 g DM, 
respectively, while in mycelial cultures it was 0.00209 and 
0.00085 mg/100 g DM (Table 1). In addition, betulin was 
isolated and spectrophotometrically identified in biomass. 
The existence of betulin was confirmed by the presence 
of the following signals: 1H NMR (300 MHz, CHLORO-
FORM-d) d ppm 4.68 (1 H, d, J = 2.34 Hz), 4.58 (1 H, dd, 
J = 2.34, 1.17 Hz), 3.79 (1 H, dd, J = 10.55, 1.76 Hz), 3.33 
(1 H, d, J = 10.55 Hz), 3.18 (1 H, dd, J = 10.84, 4.98 Hz), 
2.38 (1 H, td, J = 10.70, 5.57 Hz), 1.68 (s), 1.02 (s), 0.98 (s), 
0.97 (s), 0.82 (s), 0.76 (s).
For example, in fruiting bodies of another arboreal spe-
cies of mushroom Inonotus obliquus, the content of betu-
linic acid and betulin was determined at 103.0 mg/g and 
1490.0 mg/g respectively [34].
Betulin exhibits a broad spectrum of biological activity 
with respect to many diseases, including anticancer activity. 
It interacts with Sterol Regulatory Element-Binding Proteins 
(SREBP), which participates in the activation of the expres-
sion of genes involved in the synthesis of cholesterol, fatty 
acids and triglycerides [35]. Compounds from the group 
of terpenoids with anti-inflammatory, antiproliferative and 
anticancer potential have been isolated from numerous spe-
cies of mushrooms living on wood. One of these is Poria 
cocos. An anti-inflammatory activity of extracts from this 
mushroom species has been demonstrated in an in vitro 
model using RAW 264.7 macrophages. A decrease in the 
generation of pro-inflammatory mediators by inactivating 
the NF-κB signaling pathway was observed [36].
In turn, the anticancer activity of fungal terpenoids was 
tested on the U937 line. The concentration and time-depend-
ent antiproliferative effect and pro-apoptotic effects of the 
examined extracts is related to the release of cytochrome C 
to the cytosol, activation of caspases − 3, − 8 and − 9, deg-
radation of PARP and mitochondrial membrane potential 
loss. The obtained results indicate the potential of P. cocos in 
the treatment of leukemia [37]. A series of triterpenes with 
a similar inhibitory effect on the NF-κB signaling pathway 
has been isolated from another species, Inonotus obliquus 
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[38]. In turn, the extracts from Antrodia camphorata inhibit 
the proliferation of cancer cells, and also show a reduction 
of NO, TNF-α and IL-12 [39].
All examined extracts revealed varied cytotoxic effects 
against the cell lines used in the experiment. The myce-
lium extract exhibited significant cytotoxic activity against 
DU145 prostate cancer cells (27.28 ± 0.98 and 5.37 ± 0.31% 
of viable cells at 20 and 50 µg/mL, respectively) and a mod-
erate effect was observed against A375 melanoma cell lines 
(21.39 ± 1.4% of viable cells at 50 µg/mL), while the other 
melanoma cell line, WM795, seemed to be less vulnera-
ble, with 74.21 ± 1.29% of viable cells at 50 µg/mL. Most 
importantly, the extract had no cytotoxic effect on normal 
human skin fibroblasts and prostate epithelial cells, which 
indicates its selectivity. The results of the cytotoxic effect 
of fruiting body extracts indicated a moderate influence on 
the viability of A375 melanoma and DU145 prostate can-
cer cells (52.12 ± 1.45 and 69.32 ± 1.69% of viable cells at 
50 µg/mL, respectively), while no impact was observed on 
WM795 melanoma cells (96.22 ± 1.63% of viable cells at 
50 µg/mL). Normal human skin fibroblasts were unaffected 
by the extract, but a strong cytotoxic effect was observed 
on normal prostate epithelial cells (5.21 ± 0.43% of viable 
cells at 50 µg/mL) (Figs. 2, 3). The cause of differences in 
the cytotoxicity of extracts obtained from fruiting bodies 
and mycelial cultures can be related to the different chemi-
cal composition of the material in vitro and in vivo. Extracts 
from fungal cultures possess a higher content of biological 
active sterols or triterpenoids.
Extracts obtained from fruiting bodies show higher activ-
ity, with respect to normal prostate cells, in relation to cul-
tures, while cultures have a stronger influence on melano-
mas, especially A375, and to a lesser extent WM795. To the 
best of our knowledge, our study is the first to demonstrate 
the cytotoxic potential of mycelial cultures of F. betulina on 
prostate cancer and melanoma cells, while we have been able 
to find only one similar experiment on the cytotoxic activity 
of the mycelium (i.e. Cyranka et al.) against human colon 
Fig. 1  HPLC chromatographic separation of triterpenoids from mycelial culture of 1—betulinic acid, 2—betulin. UV spectrum of betulin
Fig. 2  Cytotoxic activity of extracts from fruiting bodies of Fomitop-
sis betulina 
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cancer LS180 and normal CCD 841 CoTr cells. Ether and 
ethanolic extracts of the tested mushroom revealed selective 
cytotoxic and antiproliferative activity against cancer cells, 
with almost no impact on normal colon cells [8].
Some authors have described the impact of F. betulina 
fruiting bodies on a number of murine and human cancer 
cell lines. Kaczor et al. demonstrated a significant cytotoxic 
activity of the ether extract on FTC238 human thyroid car-
cinoma, SK-N-AS neuroblastoma, T47D breast carcinoma, 
Hep-2 larynx carcinoma and HeLa cervix carcinoma, in a 
time- and dose-dependent manner, with the most profound 
effect being for FTC238 cells. Moreover, the tested extract 
induced cell cycle arrestment in S-phase for thyroid carci-
noma cells [40].
In a study by Tomasi et al., the moderate cytotoxic effect 
of methanolic extract of F. betulina fruiting bodies was 
observed against 3 LL murine Lewis lung carcinoma and 
L1210 lymphocytic leukaemia cells, with IC50 values of 
88.2 and 77.5 µg/mL, respectively [41].
Ethanolic extract from F. betulina fruiting bodies was 
also tested against human colon epithelial cells—CaCo-2 
and HT-29—by Doskocil et al., and the results showed that 
the extract was cytotoxic against HT-29 (IC50 73 µg/mL), 
but not CaCo-2 cells [42].
Thus, the results of our study are comparable with those 
of other authors. Moreover, this is the first study to describe 
the cytotoxic impact of F. betulina fruiting bodies against 
prostate cancer and melanoma cells.
In the A549 cells incubated with extracts from fruiting 
bodies and mycelial cultures of F. betulina was determined 
using Western Blot technique, the expression of a COX-2 
protein associated with the inflammatory process. As an 
internal control, glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) was used.
No apoptosis or reduced viability of A549 cells was 
observed after incubation with fruiting bodies and myce-
lium extracts in LPS-activated cells. The highest expression 
of COX-2 was observed in LPS activated A549 cells com-
pared to the control. Cyclooxygenase expression was lower 
in samples incubated with mycelium extracts of 10 µM and 
25 µM activated with LPS compared to extracts from fruit-
ing bodies (Fig. 4).
The primary and secondary metabolites contained in the 
mushrooms exhibit a beneficial effect on immune system 
functioning: primarily anti-inflammatory and antioxidant 
activity. Natural products containing bioactive compounds 
with the mentioned effect can be used to reduce oxidative 
damage and inflammation in the human body. Chemical 
compounds contained in mushrooms also affect the prolif-
eration and differentiation of lymphocyte populations, as 
well as the migration and adhesion of these cells. They can 
also inhibit the synthesis of inflammation mediators, i.e. 
cytokines, interleukins, prostaglandins, or nitric oxide by 
inhibiting the pro-inflammatory signal pathways associated 
with NF-κB nuclear receptors [43].
Our study on the anti-inflammatory activity of extracts of 
both fruiting bodies and mycelium includes anti-inflamma-
tory compounds that can be used in the development of new 
anti-inflammatory drugs.
Numerous studies indicate that compounds with a lan-
tostanoid structure possess an anti-inflammatory activity. 
Wangun et al. isolated and fully characterized three com-
pounds with lanostanoid structures which demonstrated 
cyclooxygenase I inhibition activity, and in addition these 
compounds proved to be promising anti-inflammatory agents 
by inhibiting 3-α-hydroxysteroid dehydrogenase. Numerous 
studies on anti-inflammatory activity have focused on an 
analysis of extracts obtained from fruiting bodies. Methanol 
Fig. 3  Cytotoxic activity of extracts from mycelial culture of Fomi-
topsis betulina 
Fig. 4  Relative expression of COX-2 in A549 cells supplemented 
with extracts from fruiting bodies (fb) and mycelial cultures (mc) and 
activated with LPS
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extracts from Pleurotus pulmonarius evoke an effect similar 
to diclofenac, while methanol extract from oyster mushroom 
causes inflammation of blood vessels [44].
Edible species have been widely studied in terms of anti-
inflammatory activity. The study conducted by Muszyńska 
et al. demonstrated the effect of I. badia extracts derived 
from biomass on simultaneous expression of COX-2, cPGES 
and GSTM1 proteins and the activity of NF-ĸB and PPARγ 
transcription factors in RAW 264.7 macrophages. High lev-
els of expression of COX-2 and cPGES2 pro-inflammatory 
proteins and AHR proteins in LPS activated A549 cells have 
been found in C. cibarius species, and the addition of C. 
cibarius biomass extracts enriched with zinc salts inhibited 
the expression of the examined proteins [16, 45].
Conclusion
To the our best knowledge this study for a first time present 
a comparison of qualitative and quantitative data regarding 
bioactive secondary metabolites in the fruiting bodies and 
biomass of F. betulina, as well as results of in vitro anti-
inflammatory and cytotoxic activity against melanoma and 
prostate cell lines. Despite records of the use of this species 
in folk medicine, there has not been any previous charac-
terization of the chemical or pharmacological potential of 
mycelial cultures. The results of biological activity assays 
demonstrate that extracts from F. betulina show cytotoxic 
and anti-inflammatory activities at different magnitudes of 
potency. The mycelial culture extract might be a potential 
supporting agent in prostate cancer therapy, but further stud-
ies are needed.
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